Sarah James
Stock Analyst at Barclays
(2.12)
# 1,538
Out of 4,667 analysts
266
Total ratings
37.25%
Success rate
-4.97%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Maintains: Overweight | $30 → $17 | $13.98 | +21.60% | 14 | Nov 14, 2024 | |
| THC Tenet Healthcare | Maintains: Overweight | $168 → $177 | $151.84 | +16.57% | 19 | Oct 30, 2024 | |
| UHS Universal Health Services | Reiterates: Neutral | $219 | $197.52 | +10.87% | 24 | Oct 25, 2024 | |
| MOH Molina Healthcare | Reiterates: Overweight | $406 | $294.64 | +37.80% | 11 | Oct 24, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $400 | $323.39 | +23.69% | 19 | Oct 23, 2024 | |
| ELV Elevance Health | Maintains: Overweight | $600 → $485 | $397.48 | +22.02% | 18 | Oct 18, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $591 → $644 | $600.50 | +7.24% | 16 | Oct 16, 2024 | |
| TBRG TruBridge | Reiterates: Overweight | $13 | $16.52 | -21.31% | 5 | Oct 4, 2024 | |
| SGRY Surgery Partners | Reiterates: Overweight | $43 | $22.51 | +91.03% | 12 | Oct 4, 2024 | |
| HCAT Health Catalyst | Reiterates: Overweight | $16 | $7.36 | +117.39% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $392 | $333.00 | +17.72% | 18 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $90 | $39.10 | +130.18% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $395 | $293.97 | +34.37% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $56.83 | +9.10% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $90 | $59.10 | +52.28% | 11 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $5.42 | +176.75% | 10 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $4.10 | +21.95% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $9.00 | +11.11% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $90.00 | +12.22% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $161.40 | -17.60% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $16.27 | +158.14% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $4.70 | +6.38% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $5.77 | -13.34% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $11.95 | +75.73% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $82.16 | -52.53% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $73.73 | +161.77% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.83 | - | 2 | Mar 1, 2017 |
Progyny
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $13.98
Upside: +21.60%
Tenet Healthcare
Oct 30, 2024
Maintains: Overweight
Price Target: $168 → $177
Current: $151.84
Upside: +16.57%
Universal Health Services
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $197.52
Upside: +10.87%
Molina Healthcare
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $294.64
Upside: +37.80%
The Cigna Group
Oct 23, 2024
Reiterates: Overweight
Price Target: $400
Current: $323.39
Upside: +23.69%
Elevance Health
Oct 18, 2024
Maintains: Overweight
Price Target: $600 → $485
Current: $397.48
Upside: +22.02%
UnitedHealth Group
Oct 16, 2024
Maintains: Overweight
Price Target: $591 → $644
Current: $600.50
Upside: +7.24%
TruBridge
Oct 4, 2024
Reiterates: Overweight
Price Target: $13
Current: $16.52
Upside: -21.31%
Surgery Partners
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $22.51
Upside: +91.03%
Health Catalyst
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $7.36
Upside: +117.39%
Oct 4, 2024
Reiterates: Overweight
Price Target: $392
Current: $333.00
Upside: +17.72%
Oct 4, 2024
Reiterates: Neutral
Price Target: $90
Current: $39.10
Upside: +130.18%
Oct 1, 2024
Reiterates: Neutral
Price Target: $395
Current: $293.97
Upside: +34.37%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $56.83
Upside: +9.10%
Oct 1, 2024
Reiterates: Overweight
Price Target: $90
Current: $59.10
Upside: +52.28%
Sep 20, 2024
Reiterates: Overweight
Price Target: $15
Current: $5.42
Upside: +176.75%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $4.10
Upside: +21.95%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $9.00
Upside: +11.11%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $90.00
Upside: +12.22%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $161.40
Upside: -17.60%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $16.27
Upside: +158.14%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.70
Upside: +6.38%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $5.77
Upside: -13.34%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $11.95
Upside: +75.73%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $82.16
Upside: -52.53%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $73.73
Upside: +161.77%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.83
Upside: -